| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3 | 369 | 295 | - | - | - | 667 |
| - | - | - | - | - | 19 | 23 | - | - | - | 42 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 259 |
| 271 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 667 | 69.5% | -3.99 | 42 | 13.4% |
| PLP(L) | 147 | 15.3% | 0.24 | 174 | 55.6% |
| CentralBrain-unspecified | 111 | 11.6% | -0.30 | 90 | 28.8% |
| Optic-unspecified(L) | 34 | 3.5% | -inf | 0 | 0.0% |
| SLP(L) | 1 | 0.1% | 2.81 | 7 | 2.2% |
| upstream partner | # | NT | conns MeVP39 | % In | CV |
|---|---|---|---|---|---|
| MeTu2a (L) | 29 | ACh | 123 | 13.5% | 0.5 |
| MeVP15 (L) | 12 | ACh | 107 | 11.7% | 0.5 |
| Dm-DRA1 (L) | 21 | Glu | 99 | 10.9% | 0.8 |
| Cm4 (L) | 40 | Glu | 85 | 9.3% | 0.6 |
| MeTu3a (L) | 19 | ACh | 63 | 6.9% | 0.6 |
| MeVPMe10 (R) | 2 | Glu | 51 | 5.6% | 0.3 |
| MeTu3b (L) | 18 | ACh | 44 | 4.8% | 0.7 |
| CB2377 (L) | 2 | ACh | 40 | 4.4% | 0.1 |
| aMe22 (L) | 1 | Glu | 23 | 2.5% | 0.0 |
| Cm14 (L) | 7 | GABA | 18 | 2.0% | 0.5 |
| Dm2 (L) | 8 | ACh | 15 | 1.6% | 0.4 |
| aMe13 (R) | 1 | ACh | 13 | 1.4% | 0.0 |
| MeVPaMe2 (R) | 1 | Glu | 13 | 1.4% | 0.0 |
| CB3676 (L) | 1 | Glu | 11 | 1.2% | 0.0 |
| MeTu3c (L) | 9 | ACh | 11 | 1.2% | 0.3 |
| MeTu2b (L) | 8 | ACh | 11 | 1.2% | 0.4 |
| Mi15 (L) | 10 | ACh | 11 | 1.2% | 0.3 |
| MeVPLo2 (R) | 3 | ACh | 10 | 1.1% | 0.4 |
| Cm21 (L) | 5 | GABA | 10 | 1.1% | 0.5 |
| MeVP14 (L) | 8 | ACh | 10 | 1.1% | 0.3 |
| aMe23 (L) | 1 | Glu | 8 | 0.9% | 0.0 |
| MeVPLo2 (L) | 4 | ACh | 8 | 0.9% | 0.4 |
| MeVPMe4 (R) | 1 | Glu | 7 | 0.8% | 0.0 |
| aMe12 (L) | 3 | ACh | 7 | 0.8% | 0.8 |
| Cm20 (L) | 5 | GABA | 7 | 0.8% | 0.3 |
| Cm34 (L) | 1 | Glu | 6 | 0.7% | 0.0 |
| CB2377 (R) | 2 | ACh | 6 | 0.7% | 0.7 |
| Cm12 (L) | 4 | GABA | 6 | 0.7% | 0.3 |
| aMe6c (L) | 2 | Glu | 5 | 0.5% | 0.2 |
| aMe3 (L) | 1 | Glu | 4 | 0.4% | 0.0 |
| Cm28 (L) | 2 | Glu | 4 | 0.4% | 0.5 |
| Cm22 (L) | 4 | GABA | 4 | 0.4% | 0.0 |
| MeVP6 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| MeVC24 (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| LoVP54 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| aMe17e (L) | 1 | Glu | 3 | 0.3% | 0.0 |
| MeVC27 (R) | 1 | unc | 3 | 0.3% | 0.0 |
| MeVP5 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| Tm20 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| Cm8 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| MeTu1 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| aMe9 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| MeVC21 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MeVP38 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| LoVP96 (L) | 1 | Glu | 2 | 0.2% | 0.0 |
| MeLo6 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| Tm37 (L) | 2 | Glu | 2 | 0.2% | 0.0 |
| MeTu4a (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| 5thsLNv_LNd6 (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| Cm5 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| TmY10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu4c (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe6b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP322 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SMP229 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 1 | 0.1% | 0.0 |
| OCG02c (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm13 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP16 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| Cm11a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP22 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP_unclear (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP20 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP63 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP270 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe26 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVC5 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC20 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPLp2 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| AVLP594 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| DNc02 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| SMP001 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 1 | 0.1% | 0.0 |
| aMe17a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns MeVP39 | % Out | CV |
|---|---|---|---|---|---|
| FB8B (L) | 2 | Glu | 115 | 18.1% | 0.0 |
| MeVP15 (L) | 13 | ACh | 108 | 17.0% | 0.5 |
| SLP364 (L) | 2 | Glu | 61 | 9.6% | 0.5 |
| AVLP594 (L) | 1 | unc | 45 | 7.1% | 0.0 |
| aMe13 (R) | 1 | ACh | 32 | 5.0% | 0.0 |
| SMP217 (L) | 3 | Glu | 26 | 4.1% | 0.6 |
| Cm14 (L) | 10 | GABA | 17 | 2.7% | 0.5 |
| SLP067 (L) | 1 | Glu | 16 | 2.5% | 0.0 |
| SMP527 (L) | 1 | ACh | 16 | 2.5% | 0.0 |
| AVLP594 (R) | 1 | unc | 13 | 2.1% | 0.0 |
| CL356 (L) | 2 | ACh | 12 | 1.9% | 0.3 |
| SMP228 (L) | 4 | Glu | 12 | 1.9% | 0.8 |
| MeVC20 (L) | 2 | Glu | 10 | 1.6% | 0.2 |
| aMe22 (L) | 1 | Glu | 9 | 1.4% | 0.0 |
| CB1791 (L) | 1 | Glu | 9 | 1.4% | 0.0 |
| CB0386 (L) | 1 | Glu | 9 | 1.4% | 0.0 |
| SMP529 (L) | 1 | ACh | 8 | 1.3% | 0.0 |
| SMP229 (L) | 4 | Glu | 8 | 1.3% | 0.6 |
| LNd_b (L) | 2 | ACh | 7 | 1.1% | 0.1 |
| AOTU056 (L) | 1 | GABA | 6 | 0.9% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 6 | 0.9% | 0.0 |
| Cm13 (L) | 3 | Glu | 6 | 0.9% | 0.4 |
| MeVP14 (L) | 6 | ACh | 6 | 0.9% | 0.0 |
| SLP076 (L) | 2 | Glu | 5 | 0.8% | 0.6 |
| aMe13 (L) | 1 | ACh | 4 | 0.6% | 0.0 |
| LoVP96 (L) | 1 | Glu | 4 | 0.6% | 0.0 |
| Cm3 (L) | 2 | GABA | 4 | 0.6% | 0.5 |
| Cm21 (L) | 2 | GABA | 4 | 0.6% | 0.5 |
| aMe17b (L) | 2 | GABA | 4 | 0.6% | 0.5 |
| SLP249 (L) | 2 | Glu | 4 | 0.6% | 0.0 |
| aMe4 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| LHPV5i1 (L) | 1 | ACh | 3 | 0.5% | 0.0 |
| MeVC27 (R) | 1 | unc | 3 | 0.5% | 0.0 |
| MeLo6 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CB2648 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| LoVP73 (L) | 1 | ACh | 2 | 0.3% | 0.0 |
| CL014 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| MeVP58 (L) | 1 | Glu | 2 | 0.3% | 0.0 |
| Cm31b (L) | 1 | GABA | 2 | 0.3% | 0.0 |
| Cm8 (L) | 2 | GABA | 2 | 0.3% | 0.0 |
| Cm7 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeLo3b (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Cm10 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| Cm12 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SLP267 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| TmY10 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Tm34 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3118 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| CB3055 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Pm4 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVC24 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP064 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| Lat1 (L) | 1 | unc | 1 | 0.2% | 0.0 |
| Cm28 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| Cm24 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP63 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| SMP183 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| LoVP74 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| SMP201 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| SLP250 (L) | 1 | Glu | 1 | 0.2% | 0.0 |
| MeVP38 (L) | 1 | ACh | 1 | 0.2% | 0.0 |
| aMe_TBD1 (L) | 1 | GABA | 1 | 0.2% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.2% | 0.0 |